A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level

Author: Parsanezhad Mohammad  

Publisher: Springer Publishing Company

ISSN: 0932-0067

Source: Archives of Gynecology and Obstetrics, Vol.269, Iss.2, 2004-01, pp. : 125-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content